Eibhlin Mulroe, of Cancer Trials Ireland, speaks about the re-opening of hospital sites for clinical trials

During our virtual panels series discussion on December 3rd, Eibhlin Mulroe spoke about the difficulties of performing clinical trials in hospitals during the first and second wave of the pandemic.

Our speakers had an in-depth discussion about the impact of Covid-19 on clinical trials in oncology. You can watch the full discussion here.

“In the second wave, we really wanted to try and get our trials back up and running… ethical reviews are taking longer as a result of Covid.”